-
-
-
-
-
-
-
Baird Downgrades Carisma Therapeutics Inc (CARM) to Neutral
-
-
-
-
-
-
-
Carisma Therapeutics (CARM) Appoints Sohanya Cheng to its Board
-
-
-
-
-
-
-
Carisma Therapeutics (CARM) Granted FDA Fast Track Designation for CT-0525 for the Treatment of HER2-overexpressing Solid Tumors
408,609 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

